Event ContactsPaid membership required to see this information
As the premier hematology event in malignant and non-malignant hematology, this meeting will provide attendees with an invaluable educational experience and the opportunity to:
- Examine the latest clinical advances on topics covering malignant and non-malignant hematology.
- Explore the year's most significant scientific discoveries and relevant key updates in key areas of the field.
- Build new partnerships and connect old friends through the meeting attendee network.
- Stay current on industry trends and learn about the latest products and services used in research and patient care.
About the Expo:
- Product Theaters where exhibitors share research findings on products and provide product details
- Free lunch on Sunday and Monday for attendees and exhibitors
- The latest technology and research as well as a wide range of new products and services on display
- Medical Supplies
- Clinical Diagnostics
- Practice Management
Exhibiting at the ASH annual meeting puts your organization in front of more than 20,000 hematologists and other health-care professionals from all 50 states and nearly 100 countries outside the United States.
Join nearly 300 pharmaceutical companies, medical suppliers, clinical diagnostic and research-based companies, publishers, and nonprofit organizations by exhibiting at the 55th ASH Annual Meeting and Exposition this December!
Exhibiting will enable you to:
-Reach influential physicians outside of their busy practices,
-Gain visibility for your company in a competitive marketplace,
-Develop lasting customer relationships and strengthen existing ones,
-Introduce new products and services and give product demonstrations to a highly targeted audience,
-Generate new sales leads.
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
Don't wait to register for the 2015 ASH Annual Meeting & Exposition - American Society Of Hematology. You'll meet influential people and maximize your opportunities for success. Start now by accessing the information below.
|Conference/Event Dates:||12/05/2015 - 12/08/2015|
|Expo/Exhibit Dates:||12/05/2015 - 12/07/2015|
|Expo/Exhibit Hours:||Sat, 11am-5pm; Sun, 10am-5pm; Mon, 10am-2pm|
|Other Industries:||Business, Internal Medicine, Oncology-Hematology, Pathology, Professional Healthcare, Sciences|
|Cost to Attend:||http://events.jspargo.com/ASH15/public/content.aspx?ID=52715&sortMenu=...|
|Audience:||Hematology Clinicians and Researchers|
|Notes:||Primary Subspecialty Area:
INTERNAL MEDICINE 54%
Transfusion Medicine 1%
RESEARCH SCIENTIST 31%
Biochemistry/Molecular Biology 9%
Cell Biology 6%
Laboratory Medicine 25%
Transfusion Medicine 13%
(attendees identified up to four categories)
Direct or Lab-Based Patient Care 57%
|Venue:||Orange County Convention Center|
|Venue Phone:||(800) 345-9845|
|Venue Type:||Indoor - Convention Center|
|Official Conference Hotel:||Hotel Information:|
|Conference Hotel URL:||https://jems.jspargo.com/jemscfw/RequestBlock/default.aspx?AppType=exh...|
|Number of Exhibitors:||300 (Previous Year)|
|Exhibit Floorplan:||Click Here|
|Show Owner:||American Society Of Hematology (ASH)|
|Show Manager:||J. Spargo & Associates, Inc.|
|Prospectus PDF:||Download Exhibitor Prospectus PDF|
|Booth Size||Booth Cost||Available Amenities|
|Inline||$41.50 per sq. ft.||Electricity:||Yes||- Unknown Price|
|Island||$53.50 per sq. ft.||Water:||n/a|
|Corner||Additional $600 per open corner||Generator:||n/a|
|Meeting Room||$51.50 per sq. ft. (Applies to ASH Exhibitors only)||Marketing Vehicles Allowed:||Yes|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.
Adaptive Biotechnologies Corporation
AIDS and Cancer Specimen Resource
Alexion Pharmaceuticals, Inc.
Alphamed Press / The Oncologist
AMAG Pharmaceuticals, Inc.
American Association for Cancer
American Board of Internal Medicine
American Porphyria Foundation
American Regent, Inc.
American Society for Apheresis
American Society for Blood &
Marrow Transplantation (ASBMT)
American Society of Clinical
American Society of Hematology
American Society of Pediatric
Amyloidosis Support Groups, Inc.
Aplastic Anemia and MDS
International Foundation, Inc.
Argon Medical Devices, Inc.
ARIAD Pharmaceuticals Inc.
AROG Pharmaceuticals and Mentrik
ASCP (American Society For Clinical
Astellas Pharma US, Inc.
Baxter Healthcare Corporation
Best Theratronics Ltd.
Biosafe America, Inc.
BioView (USA) Inc.
Cancer Genetics, Inc.
Center for Medicine in the Public
Cesca Therapeutics Inc.
Chiltern (formerly Ockham
Chronic Lymphocytic Leukaemia
Australian Research Consortium
CIBMTR (Center for International
Blood & Marrow Transplant
Cincinnati Children’s Medical Center
City of Hope National Medical Center
Clarient, A GE Healthcare Co.
Cleveland Clinic Laboratories
Cleveland Clinic Taussig Cancer
Clinical Advances in Hematology and
Clinical Oncology News
College of American Pathologists
Cooley’s Anemia Foundation
CTI BioPharma Corp.
Dana Farber Partners Cancer Care
Diplomat Specialty Pharmacy
DRG International, Inc.
Emmaus Medical, Inc.
Enzyme Research Laboratories, Inc.
European Hematology Association
European LeukemiaNet (ELN)
Fanconi Anemia Research Fund, Inc.
Foundation for Sickle Cell Disease
Foundation for the Accreditation of
Cellular Therapy (FACT)
Foundation for the Research and
Cure of Lymphoma in Ticino
Foundation for Women & Girls with
Foundation Medicine, Inc.
Gene Tools, LLC
Gensavis Pharmaceuticals, LLC
Gilead Sciences, Inc.
Haematologic Technologies, Inc.
Harborside Press, LLC
Health Volunteers Overseas
Hematology Speciality Association
HemOnc Today and Healio.com By
Infinity Pharmaceuticals, Inc.
International Myeloma Foundation
International Society on Thrombosis
Janssen Pharmaceutical Companies
of Johnson & Johnson
Janssen Pharmaceuticals, Inc.
Jazz Pharmaceuticals Inc.
John Theurer Cancer Center -
Hackensack University Medical
John Wiley & Sons, Inc.
KaloBios Pharmaceuticals Inc
Karger Publishers, Inc.
Laboratory for Personalized
Lippincott Williams & Wilkins
Machaon Diagnostics, Inc.
Managing Hematologic Malignancies
Mayo Medical Laboratories
MD Anderson Cancer Center
Merck & Co., Inc.
Miltenyi Biotec, Inc.
Miraca Life Sciences
Moffitt Cancer Center
MPE (Myeloma Patients Europe)
MRC - Holland
Multiple Myeloma Research
National Cancer Institute
National Death Index
National Heart, Lung and Blood
National Institute of Diabetes and
Digestive and Kidney Diseases
National Marrow Donor Program
Nature Publishing Group
Novo Nordisk, Inc.
Oncology Group/ Div of UBM Medica
Otsuka America Pharmaceutical, Inc.
Patient Access Network
Physicians’ Education Resource, LLC
Platelet Disorder Support Association
Prothena Biosciences Inc.
Rare Disease Therapeutics, Inc.
Sarah Cannon Research Institute
Seattle Cancer Care Alliance
Sigma-Tau Pharmaceuticals, Inc.
Society for Immunotherapy of Cancer
Spectrum Pharmaceuticals, Inc.
St. Mary’s Hospital
Stanford Anatomic Pathology &
STEMCELL Technologies, Inc.
Sterling Pathology National
Studio ER Congressi s.r.l.
Sunesis Pharmaceuticals, Inc.
Sure-Tech Diagnostic Associates Inc.
Targeted Therapeutics Consulting
TG Therapeutics, Inc.
The Binding Site, Inc.
The Double Hit Lymphoma
The Jackson Laboratory
The JAMA Network
The Japanese Society of Hematology
The Leukemia & Lymphoma Society
The Lynx Group
The Mastocytosis Society
Turkish Society of Hematology
University of Chicago Comprehensive
Varian Medical Systems
Worldwide Clinical Trials